ARCHIVES

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 11 Issue 1, Spring 1997 Special Report: The Cancer Bill

April 13, 1997

DCPC Board Backs Diet Fit Trial

October 20, 1989

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

“Mini-Transplantation” In Testing For Treatment Of Multiple Myeloma

January 25, 2002

NCI Releases List of Cancer Center Core Grant Funding for FY 2005; Univ. of New Mexico is the Newest NCI-Designated Center.

March 3, 2006

Sausville to lead clinical research at Maryland.

December 5, 2003